Published • loading... • Updated
Liver Injury Affects One in Eight Patients on Immune Checkpoint Inhibitors
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Liver Injury Affects One in Eight Patients on Immune Checkpoint Inhibitors
A retrospective study of 682 patients in Tianjin found 12.17 percent developed liver injury on immune checkpoint inhibitor therapy, with cholestatic injury predominating and a neutrophil-to-lymphocyte ratio above 3 linked to poor six-month recovery.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
